Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001193125-26-041306·ALX ONCOLOGY HOLDINGS INC
Schedule 13G ownership disclosure
ALX Oncology Holdings, Inc.
Common Stock, par value $0.001 per share · CUSIP: 00166B105
Event date: 2026-01-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TCG Crossover GP II, LLC
Shares: 6,505,925 · Class: 5.0%
- TCG Crossover Fund II, L.P.
Shares: 6,505,925 · Class: 5.0%
- TCG Crossover GP III, LLC
Shares: 6,505,924 · Class: 5.0%
- TCG Crossover Fund III, L.P.
Shares: 6,505,924 · Class: 5.0%
- Chen Yu
Shares: 13,011,849 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-041306
- Form type
- SCHEDULE 13G
- Filer
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK 1810182
- Filed
- Feb 06, 2026
- Reporting period
- Jan 30, 2026
- Description
- Schedule 13G beneficial ownership